Verrica Pharmaceuticals Announces Closing of $125 Million Debt Financing with OrbiMed - MyChesCo
Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) closes $125 million debt financing with OrbiMed, a top healthcare investment firm. Catch the latest update.
MyChesCo
